9 Comments
User's avatar
Eve D's avatar

"...now recommends boosters only for individuals aged 75 and over, residents of care homes, and those with specific clinical vulnerabilities". A continued effort to cull the 'useless eaters' who are viewed as 'draining' gov't monies. These toxic jabs are no better for people over 75 than they are for anyone else. It's criminal.

Expand full comment
Peter W's avatar

When there are bad side effects they can blame it on other things that many elders suffer. It would be too obvious on younger, healthier generations. Cut your losses and just sell what you can to the elderly.

Expand full comment
Kagsy's avatar

The FDA should be shut down and a new agency started with new staffing.

A leopard can’t change its spots.

Expand full comment
Stan Hanchard's avatar

I am older than 75 and Never had a COVID Jab AND NEVER will. I say to you EVIL BASTARDS go

stick your JABS where the Sun DON'T SHINE. I am fit and very healty.....So I not want and Don't Need YOUR POISEN.....!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Expand full comment
Keith Dudleston's avatar

In the package insert (Full prescribing Information) on page 12 under "Serious Adverse Events" you will find:

"Serious adverse events were reported by 2.7% of participants (n=156) who received MNEXSPIKE and 2.6% of participants (n=151) who received the comparator vaccine through a median follow-up of 8.8 months."

There was no placebo control comparison group, and no mention of "all cause" mortality rates. Maybe that will come under the new regime.

Expand full comment
Tonya's avatar

An almost 3% chance of a serious adverse event for trial participants. What will the rate be in the vulnerable populations for which they are recommending these shots? Certainly even higher than that.

Expand full comment
Seacat's avatar

That's the (financial ) power of Big Pharma at the 'ship's wheel'....as on an old sailing ship with a wooden wheel, there is a heavy rope ( Pharma) attached to the wheel tying it (FDA) down on the deck.

Expand full comment
Tonya's avatar

"...only about half received the mNEXSPIKE vaccine, while the remainder received an earlier Moderna product as a comparator. There was no placebo comparison."

In addition to that, I can't believe that they found 11,400 covid-vaccine-naïve individuals who had avoided the previous shots for years, but were then willing to become test subjects for the new iteration. So that means that the comparison is probably between a group of people who had several previous covid shots and another group that also had several previous covid shots plus one dose of the new product. How can a trial like that be expected to reveal any useful information?

EDIT: I just read through the insert, and all of the test subjects except one did indeed have previous doses of covid vaccines. Plus, many of them had serological evidence of previous infections.

Expand full comment
Shelagh Anne Shackleton's avatar

My only quibble is with the rate of serious adverse events of special interest.

I would put the rate of diagnosed myocarditis cases alone at 3 percent and subclinical myocarditis at 30 percent in the age group 12 to 18 years.

This is a very serious event as myocarditis leads to sudden death or congestive cardiac failure progressing to death. Over a five year period 50 percent of myocarditis sufferers die, after ten years 80 percent of myocarditis sufferers die.

This is a monumental health emergency. But the" Powers that Be" do not care so long as the kids who are culled have at least one comorbidity.

Expand full comment